Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

New AI tool promises faster vaccine development by predicting T cell epitopes

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell vaccine candidates.

29 Jan 2025

Genetic fingerprint could help predict antibiotic resistance in bacteria

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World Health Organization estimates it could surpass cancer and heart disease as the leading cause of death as more bacteria develop defenses to the drugs designed to combat them.

29 Jan 2025

AI technology uncovers genetic factors and treatment options for Parkinson's

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.

28 Jan 2025

New system uses acoustic waves to separate tumor cells with precision

Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World Health Organization.

28 Jan 2025

New brain biomarker identifies pain sensitivity and may predict chronic pain risk

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain sensitivity and treatment strategies.

28 Jan 2025

Study uncovers distinct blood protein signature in children with Long COVID

Distinct protein profiles linked to inflammation and angiogenesis found in children with Long COVID, paving the way for improved diagnostics and therapies.

28 Jan 2025

Machine learning could be a complementary decision-support tool for assessing depression

Depression impacts an estimated 18 million Americans each year, yet depression screening rarely occurs in the outpatient setting.

27 Jan 2025

Mount Sinai leads the way with first HYDROS Robotic System procedure in New York City

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged prostate.

27 Jan 2025

Study reveals impact of fava bean proteins on sensory cells in the mouth

Researchers at the Leibniz Institute for Food Systems Biology at the Technical University of Munich have for the first time investigated how protein structures derived from fava beans affect a cellular model of human oral tactile cells.

25 Jan 2025

New research highlights critical challenges facing radiology

In one of the largest global surveys of radiologists from across 50 countries, new research from Everlight Radiology highlights critical challenges facing the field of radiology. Radiology Unlocked: The Global Radiologist Report 2025, reveals radiologists’ first hand insights on the critical pressures facing the field of radiology, including the incidence of burnout and stress, the dangers of overnight working, the potential (and pitfalls) of AI, and the opportunities presented by outsourcing, as well as exploring potential solutions.

25 Jan 2025

Immune environment found to influence success of leukemia immunotherapy

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field of cancer immunotherapy.

24 Jan 2025

UH Seidman Cancer Center introduces advanced Varian Ethos 2.0 for cancer treatment

Radiation oncologists at UH Seidman Cancer Center have another powerful treatment option for patients diagnosed with many forms of cancer with the addition of Varian Ethos 2.0, capable of a new form of radiotherapy called adaptive radiotherapy.

24 Jan 2025

AI-based blood test could revolutionize diagnosis of Long Covid in children

One day Long Covid in children could be objectively diagnosed with a blood test, thanks to the help of Artificial Intelligence (AI). In fact, a study by the Università Cattolica del Sacro Cuore, Rome campus - Fondazione Policlinico Universitario Agostino Gemelli IRCCS and the Ospedale Pediatrico Bambino Gesù IRCCS, has highlighted the molecular signature of Long Covid in plasma in pediatric age and used an AI tool capable of making the diagnosis based on the results of the blood sample, with 93% accuracy.

24 Jan 2025

A global look at the gut: Scientists highlight microbiome diversity

Researchers analyzed 168,464 samples to uncover how geographic and technical factors shape global gut microbiome variation, highlighting underrepresented regions and technical biases.

23 Jan 2025

Harnessing the power of gamers to solve cancer's mysteries

Cancer is vicious. In 2025, it is expected to cause more than 618,000 U.S. deaths - nearly twice the combined populations of Merced and Modesto.

23 Jan 2025

New machine learning approach improves single-cell data analysis

Our bodies are made up of around 75 billion cells. But what function does each individual cell perform and how greatly do a healthy person’s cells differ from those of someone with a disease?

23 Jan 2025

AI-driven tools could ease nurses’ workload in healthcare sector

In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services.

23 Jan 2025

New technology tracks millions of cells simultaneously during organ development

Thanks to a new technology called Moscot ("Multi-Omics Single-Cell Optimal Transport"), researchers can now observe millions of cells simultaneously as they develop into a new organ-for example, a pancreas.

23 Jan 2025

Study reveals potential drug links to Dementia risk

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention and drug repurposing strategies.

23 Jan 2025

Insilico Medicine doses first patient in Phase I Trial of ISM6331 for mesothelioma

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I Trial of ISM6331, a novel pan-TEAD inhibitor developed from Insilico's generative chemistry engine Chemistry42, for the treatment of mesothelioma and other solid tumors.

22 Jan 2025